Skip to main content

Table 2 Distribution and concordance of S/Co values with viral RNA quantification results in patients’ groups

From: Glycylglycine promotes the solubility and antigenic utility of recombinant HCV structural proteins in a point-of-care immunoassay for detection of active viremia

Groups (n = 446)

Distribution of S/Co values among patients’ groups

Denatured Ags

Soluble Ags

 > Predictive S/Co

 < Predictive S/Co

 > Predictive S/Co

 < Predictive S/Co

Number of subjects

182 (40.84%)

264 (59.19%)

275 (61.66%)

171 (38.34%)

Concordant

122 (67.03%)

235 (89.01%)

241 (87.64%)

156 (91.23%)

Discrepant

60 (32.97%)

29 (10.98%)

34 (12.36%)

15 (8.77%)